Open AccessClinical Implication of p53 Overexpression in Breast Cancer Patients Younger than 50 Years with a Triple-negative Subtype Who Undergo a Modified Radical Mastectomy
Author(s) -
D.-S. Lee,
S. H. Kim,
Young Jin Suh,
S. Kim,
H. K. Kim,
Byoung Yong Shim
Publication year - 2011
Publication title -
japanese journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.768
H-Index - 85
eISSN - 1465-3621
pISSN - 0368-2811
DOI - 10.1093/jjco/hyr066
Subject(s) - medicine , breast cancer , modified radical mastectomy , oncology , triple negative breast cancer , immunohistochemistry , cancer , radical mastectomy , metastasis , progesterone receptor , mastectomy , estrogen receptor
The purpose of this study was to identify the clinicopathological characteristics and prognostic value of p53 overexpression in breast cancer patients treated with a modified radical mastectomy.